ZA862240B - Production of human somatomedin c - Google Patents
Production of human somatomedin cInfo
- Publication number
- ZA862240B ZA862240B ZA862240A ZA862240A ZA862240B ZA 862240 B ZA862240 B ZA 862240B ZA 862240 A ZA862240 A ZA 862240A ZA 862240 A ZA862240 A ZA 862240A ZA 862240 B ZA862240 B ZA 862240B
- Authority
- ZA
- South Africa
- Prior art keywords
- production
- dna sequences
- human
- optimal
- somatomedin
- Prior art date
Links
- 108090000723 Insulin-Like Growth Factor I Proteins 0.000 title abstract 2
- 102000004218 Insulin-Like Growth Factor I Human genes 0.000 title abstract 2
- 108091028043 Nucleic acid sequence Proteins 0.000 abstract 4
- 235000021120 animal protein Nutrition 0.000 abstract 1
- 230000002708 enhancing effect Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 229920001184 polypeptide Polymers 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/65—Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/62—DNA sequences coding for fusion proteins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/67—General methods for enhancing the expression
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/70—Vectors or expression systems specially adapted for E. coli
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
- C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
- C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones
Landscapes
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Toxicology (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Endocrinology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Gastroenterology & Hepatology (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Compounds Of Unknown Constitution (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB858507833A GB8507833D0 (en) | 1985-03-26 | 1985-03-26 | Production of human somatomedin c |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA862240B true ZA862240B (en) | 1986-11-26 |
Family
ID=10576658
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA862240A ZA862240B (en) | 1985-03-26 | 1986-03-25 | Production of human somatomedin c |
Country Status (14)
| Country | Link |
|---|---|
| EP (1) | EP0215110B1 (xx) |
| JP (4) | JPH0691832B2 (xx) |
| CN (1) | CN1034588C (xx) |
| AT (1) | ATE87977T1 (xx) |
| AU (1) | AU594950B2 (xx) |
| CA (1) | CA1339305C (xx) |
| DE (1) | DE3688225T2 (xx) |
| DK (1) | DK175223B1 (xx) |
| ES (1) | ES8705921A1 (xx) |
| GB (1) | GB8507833D0 (xx) |
| IL (1) | IL78278A0 (xx) |
| NO (1) | NO302709B1 (xx) |
| WO (1) | WO1986005810A1 (xx) |
| ZA (1) | ZA862240B (xx) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ221789A (en) * | 1986-09-12 | 1991-05-28 | Genentech Inc | Recombinant prorelaxin, its preparation and pharmaceutical compositions comprising it |
| GB8712540D0 (en) * | 1987-05-28 | 1987-07-01 | Ucb Sa | Expression of human proapolipoprotein a-i |
| US4876242A (en) * | 1987-09-21 | 1989-10-24 | Merck & Co., Inc. | Human insulin-like growth factor analoges with reduced binding to serum carrier proteins and their production in yeast |
| AUPP807899A0 (en) | 1999-01-08 | 1999-02-04 | University Of Queensland, The | Codon utilization |
| JP6018719B1 (ja) * | 2016-03-15 | 2016-11-02 | Ｂｘ新生精機株式会社 | シャッター開閉機の巻上装置 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ207842A (en) * | 1983-04-25 | 1988-02-12 | Chiron Corp | Production of human insulin-like growth factor (igf) using cdna |
| IL71991A (en) * | 1983-06-06 | 1994-05-30 | Genentech Inc | Preparation of human FGI and FGE in their processed form through recombinant AND tranology in prokaryotes |
| SE8303626D0 (sv) * | 1983-06-23 | 1983-06-23 | Kabigen Ab | A recombinant plasmid a transformant microorganism, a polydoxyrebonucleotide segment, a process for producing a biologically active protein, and the protein thus produced |
| EP0151760A1 (en) * | 1984-01-06 | 1985-08-21 | Takeda Chemical Industries, Ltd. | Novel DNA and use thereof |
| US4758512A (en) * | 1984-03-06 | 1988-07-19 | President And Fellows Of Harvard College | Hosts and methods for producing recombinant products in high yields |
-
1985
- 1985-03-26 GB GB858507833A patent/GB8507833D0/en active Pending
-
1986
- 1986-03-21 CA CA000504757A patent/CA1339305C/en not_active Expired - Lifetime
- 1986-03-25 WO PCT/US1986/000579 patent/WO1986005810A1/en active IP Right Grant
- 1986-03-25 DE DE8686902217T patent/DE3688225T2/de not_active Expired - Lifetime
- 1986-03-25 EP EP86902217A patent/EP0215110B1/en not_active Expired - Lifetime
- 1986-03-25 AU AU56657/86A patent/AU594950B2/en not_active Expired
- 1986-03-25 JP JP61501992A patent/JPH0691832B2/ja not_active Expired - Lifetime
- 1986-03-25 AT AT86902217T patent/ATE87977T1/de not_active IP Right Cessation
- 1986-03-25 ES ES553374A patent/ES8705921A1/es not_active Expired
- 1986-03-25 ZA ZA862240A patent/ZA862240B/xx unknown
- 1986-03-26 IL IL78278A patent/IL78278A0/xx unknown
- 1986-03-26 CN CN86102889A patent/CN1034588C/zh not_active Expired - Lifetime
- 1986-11-25 NO NO864724A patent/NO302709B1/no unknown
- 1986-11-26 DK DK198605698A patent/DK175223B1/da not_active IP Right Cessation
-
1994
- 1994-05-09 JP JP6117443A patent/JP2602628B2/ja not_active Expired - Lifetime
- 1994-05-09 JP JP6117430A patent/JP2568383B2/ja not_active Expired - Lifetime
- 1994-05-09 JP JP6117435A patent/JPH07102152B2/ja not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| AU594950B2 (en) | 1990-03-22 |
| ATE87977T1 (de) | 1993-04-15 |
| JPH07143896A (ja) | 1995-06-06 |
| JPH07145200A (ja) | 1995-06-06 |
| EP0215110A4 (en) | 1987-07-09 |
| ES553374A0 (es) | 1987-05-16 |
| JPH07102152B2 (ja) | 1995-11-08 |
| EP0215110A1 (en) | 1987-03-25 |
| NO864724L (no) | 1987-01-23 |
| AU5665786A (en) | 1986-10-23 |
| CN1034588C (zh) | 1997-04-16 |
| JPH0691832B2 (ja) | 1994-11-16 |
| JPH07143885A (ja) | 1995-06-06 |
| DK175223B1 (da) | 2004-07-12 |
| CA1339305C (en) | 1997-08-19 |
| NO302709B1 (no) | 1998-04-14 |
| JP2602628B2 (ja) | 1997-04-23 |
| GB8507833D0 (en) | 1985-05-01 |
| IL78278A0 (en) | 1986-07-31 |
| ES8705921A1 (es) | 1987-05-16 |
| DK569886D0 (da) | 1986-11-26 |
| DK569886A (da) | 1986-11-26 |
| JPS62502305A (ja) | 1987-09-10 |
| DE3688225T2 (de) | 1993-07-22 |
| EP0215110B1 (en) | 1993-04-07 |
| WO1986005810A1 (en) | 1986-10-09 |
| JP2568383B2 (ja) | 1997-01-08 |
| DE3688225D1 (de) | 1993-05-13 |
| CN86102889A (zh) | 1986-11-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL272698A1 (en) | Method for expressing human proapolyprotein a-j | |
| HUT46061A (en) | Dna sequences encoding hirudin-like protein and process for producing such proteins | |
| IL70414A (en) | Polypeptide having human h2-relaxin activity,double-stranded dna fragments coding therefor,vectors containing the dna fragments and methods for preparing the polypeptide,dna fragments and vectors | |
| DE3586189D1 (de) | Menge und verfahren zur herstellung rekombinierter erzeugnisse in grosser ausbeute. | |
| DK666888D0 (da) | Human vaevsfaktor-relaterende dna-segmenter, polypeptider og antistoffer | |
| CY1346A (en) | Dna sequences,recombinant dna molecules and processes for producing human interferon-like polypeptides | |
| EP0258411A4 (en) | DNA ENCODING STREPTAVIDINE, STREPTAVIDINE PRODUCED FROM IT, FUSED POLYPEPTIDES WITH AMINO ACID SEQUENCES FROM STREPTAVIDINE AND USES. | |
| PT76546B (en) | Process for preparing functional human urokinase protein | |
| DK0477971T3 (da) | Humant CNP gen og precursorprotein | |
| IE832259L (en) | Dna sequences swine growth hormone polypeptides | |
| DK568587A (da) | Dna fragmenter indeholdende alkalisk cellulasegen, rekombinante plasmider indeholdende disse dna fregmenter og rekombinante mikroorganismer | |
| GR852940B (xx) | ||
| DK358787A (da) | Vaekstfaktor, nucleotidsekvens kodende for vaekstfaktoren ekspressionsplasmid omfattende nucleotidsekvensen,vaert indeholdende plasmidet protein fremstillet af vaerten, fremgangsmaade til fremstilling af vaekstfaktoren og farmaceutisk praeparat indeholdendevaekstfaktoren | |
| AU1987088A (en) | A process for preparing a protein or polypeptide, a dna sequence coding for the polypeptide, a microorganism containing the dna sequence as well as the polypeptide and its use as a pharmaceutical preparation | |
| ZA862240B (en) | Production of human somatomedin c | |
| IL79797A (en) | Expression dna sequence for use in e.coli | |
| ZA874677B (en) | Dna sequence,recombinant dna molecules and process for producing the newcastle disease virus fusion protein or equivalent polypeptides,obtained products and preparations containing same | |
| IL85759A0 (en) | The cloning of malaria-specific dna sequences,isolation of the gene for the 140 kd protein | |
| FI934079A (fi) | Menetelmä fuusioproteiinin valmistamiseksi | |
| IE831918L (en) | Dna sequences, recomninant dna molecules, production of¹bovine growth hormone polypeptides | |
| IE871743L (en) | "dna sequence, recombinant dna molecules and process for¹producing the newcastle disease virus fusion protein or¹equivalent polypeptides, obtained products and preparations¹containing the same" |